Terms: = Pancreatic cancer AND TMPRSS2, PRSS10, 7113, ENSG00000184012, O15393 AND Treatment
6 results:
1. Comparison of ERG and SPINK1 expression among incidental and metastatic prostate cancer in Japanese men.
Koide H; Kimura T; Inaba H; Sato S; Iwatani K; Yorozu T; Furusato B; Kamata Y; Miki J; Kiyota H; Takahashi H; Egawa S
Prostate; 2019 Jan; 79(1):3-8. PubMed ID: 30051483
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy of endoscopic self-expandable metal stent placement versus surgical bypass for inoperable pancreatic cancer-related malignant biliary obstruction: a propensity score-matched analysis.
Ma KW; Chan ACY; She WH; Chok KSH; Dai WC; Tsang S; Cheung TT; Lo CM
Surg Endosc; 2018 Feb; 32(2):971-976. PubMed ID: 28779260
[TBL] [Abstract] [Full Text] [Related]
3. Molecular Discriminators of Racial Disparities in Prostate cancer.
Ateeq B; Bhatia V; Goel S
Trends Cancer; 2016 Mar; 2(3):116-120. PubMed ID: 28741531
[TBL] [Abstract] [Full Text] [Related]
4. The spectrum of neuroendocrine tumors: histologic classification, unique features and areas of overlap.
Klimstra DS; Beltran H; Lilenbaum R; Bergsland E
Am Soc Clin Oncol Educ Book; 2015; ():92-103. PubMed ID: 25993147
[TBL] [Abstract] [Full Text] [Related]
5. Molecular foundations for personalized therapy in prostate cancer.
Fisher KW; Montironi R; Lopez Beltran A; Moch H; Wang L; Scarpelli M; Williamson SR; Koch MO; Cheng L
Curr Drug Targets; 2015; 16(2):103-14. PubMed ID: 25547910
[TBL] [Abstract] [Full Text] [Related]
6. Phase II study of cytarabine in men with docetaxel-refractory, castration-resistant prostate cancer with evaluation of tmprss2-ERG and SPINK1 as serum biomarkers.
Dhani NC; Emmenegger U; Adams L; Jongstra J; Tannock IF; Sridhar SS; Knox JJ; Day JR; Groskopf J; Joshua AM
BJU Int; 2012 Sep; 110(6):840-5. PubMed ID: 22313860
[TBL] [Abstract] [Full Text] [Related]
